Shelton Capital Management Edwards Lifesciences Corp Transaction History

Shelton Capital Management

$3.62 Billion
Q2 2024

A detailed history of Shelton Capital Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Shelton Capital Management holds 3,589 shares of EW stock, worth $235,007. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,589

Previous 3,589 -0.0%

Holding current value

$235,007

Previous $342,000 3.22%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $22,585 - $28,460	-366 Reduced 9.25%	3,589 $273,000
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $12,232 - $15,028	-115 Reduced 2.83%	3,955 $512,000
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $1.97 Million - $2.27 Million	-25,053 Reduced 86.02%	4,070 $340,000
Q3 2020 Nov 09, 2020	SELL	$67.19 - $87.44 $12,161 - $15,826	-181 Reduced 0.62%	29,123 $2.33 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $1.12 Million - $1.5 Million	19,536 Added 200.0%	29,304 $2.03 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $145,070 - $224,208	-2,768 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$71.7 - $82.09 $22,083 - $25,283	-308 Reduced 10.01%	2,768 $646,000
Q3 2019 Nov 13, 2019	BUY	$61.55 - $75.43 $189,327 - $232,022	3,076 New	3,076 $676,000
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $138,625 - $160,187	2,487 Added 422.24%	3,076 $568,000
Q1 2019 May 10, 2019	SELL	$47.89 - $64.05 $119,102 - $159,292	-2,487 Reduced 80.85%	589 $3.08 Million
Q4 2018 Jan 31, 2019	SELL	$46.41 - $56.94 $142,757 - $175,147	-3,076 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$42.45 - $51.3 $130,576 - $157,798	3,076 New	3,076 $448,000
Q4 2017 Feb 06, 2018	SELL	$33.79 - $39.39 $103,938 - $121,163	-3,076 Closed	0 $0
Q3 2017 Nov 28, 2017	BUY	$36.29 - $38.83 $111,628 - $119,441	3,076 New	3,076 $336,000
Q3 2017 Nov 14, 2017	SELL	$36.29 - $38.83 $111,628 - $119,441	-3,076 Closed	0 $0
Q2 2017 Aug 14, 2017	SELL	N/A	-100 Reduced 3.15%	3,076 $364,000
Q1 2017 Nov 28, 2017	SELL	N/A	-140 Reduced 4.22%	3,176 $299,000
Q3 2016 Dec 06, 2017	BUY	N/A	3,216 New	3,216 $388,000
Q3 2016 Dec 04, 2017	BUY	N/A	3,316	3,316 $311,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.

Account

Shelton Capital Management Edwards Lifesciences Corp Transaction History